Paul Andrew Moore - Net Worth and Insider Trading

Paul Andrew Moore Net Worth

The estimated net worth of Paul Andrew Moore is at least $108,811 dollars as of 2024-11-05. Paul Andrew Moore is the Chief Scientific Officer of Zymeworks Inc and owns about 7,367 shares of Zymeworks Inc (ZYME) stock worth over $108,811. Details can be seen in Paul Andrew Moore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Andrew Moore has not made any transactions after 2024-01-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Paul Andrew Moore

To

Paul Andrew Moore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Andrew Moore owns 1 companies in total, including Zymeworks Inc (ZYME) .

Click here to see the complete history of Paul Andrew Moore’s form 4 insider trades.

Insider Ownership Summary of Paul Andrew Moore

Ticker Comapny Transaction Date Type of Owner
ZYME Zymeworks Inc 2024-01-08 Chief Scientific Officer

Paul Andrew Moore Latest Holdings Summary

Paul Andrew Moore currently owns a total of 1 stock. Paul Andrew Moore owns 7,367 shares of Zymeworks Inc (ZYME) as of January 8, 2024, with a value of $108,811.

Latest Holdings of Paul Andrew Moore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYME Zymeworks Inc 2024-01-08 7,367 14.77 108,811

Holding Weightings of Paul Andrew Moore


Paul Andrew Moore Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Andrew Moore has made a total of 1 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Zymeworks Inc is the sale of 9,799 shares on January 8, 2024, which brought Paul Andrew Moore around $105,731.

Insider Trading History of Paul Andrew Moore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Andrew Moore Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul Andrew Moore Ownership Network

Ownership Network List of Paul Andrew Moore

No Data

Ownership Network Relation of Paul Andrew Moore

Insider Network Chart

Paul Andrew Moore Owned Company Details

What does Zymeworks Inc do?

Who are the key executives at Zymeworks Inc?

Paul Andrew Moore is the Chief Scientific Officer of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and 10 percent owner Ecor1 Capital, Llc .

Zymeworks Inc (ZYME) Insider Trades Summary

Over the past 18 months, Paul Andrew Moore made 1 insider transaction in Zymeworks Inc (ZYME) with a net sale of 9,799. Other recent insider transactions involving Zymeworks Inc (ZYME) include a net sale of 6,880 shares made by Christopher Astle , a net purchase of 3,350,000 shares made by Ecor1 Capital, Llc , and a net sale of 23,904 shares made by Kenneth Galbraith .

In summary, during the past 3 months, insiders sold 0 shares of Zymeworks Inc (ZYME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,583 shares of Zymeworks Inc (ZYME) were sold and 3,350,000 shares were bought by its insiders, resulting in a net purchase of 3,309,417 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zymeworks Inc Insider Transactions

No Available Data

Paul Andrew Moore Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Andrew Moore. You might contact Paul Andrew Moore via mailing address: 114 East 4th Avenue, Suite 800, Vancouver A1 V5t 1g4.